CHAMPIONS ONCOLOGY INC

For the period ended Apr 30, 2024. Filed Jul 19, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jul 19, 2024

CSBR$4.84+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

AS OF APRIL 30

(In Thousands except for shares)

	2024	2023
ASSETS
Current assets:
Cash	$2,618	$10,118
Accounts receivable, net	9,526	8,011
Prepaid expenses and other current assets	1,495	1,328
Total current assets	13,639	19,457
Operating lease right-of-use assets, net	6,252	7,318
Property and equipment, net	5,721	7,186
Other long term assets	185	15
Goodwill	335	335
Total assets	$26,132	$34,311
LIABILITIESAND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$5,800	$5,334
Accrued liabilities	2,160	2,270
Current portion of operating lease liabilities	1,337	1,208
Other current liabilities	150	145
Deferred revenue	12,094	12,776
Total current liabilities	21,541	21,733
Non-current portion operating lease liabilities	6,093	7,391
Other non-current liabilities	401	551
Total liabilities	$28,035	$29,675
Stockholders' (deficiency) equity:
Common stock, $.001 par value; 200,000,000 shares authorized; 13,714,099 and 13,558,650 shares issued; and 13,593,766 and 13,544,228 shares outstanding at April 30, 2024 and 2023, respectively	14	14
Treasury Stock, at cost	(708)	(74)
Additional paid-in capital	83,384	82,013
Accumulated deficit	(84,593)	(77,317)
Total stockholders' (deficiency) equity	(1,903)	4,636
Total liabilities and stockholders' (deficiency) equity	$26,132	34,311

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.